Easy profits for Tabcorp shareholders
Tabcorp's latest capital raising creates an opportunity to pocket some cash for shareholders who do not wish to invest more money.
Sirtex enters remission
There’s a lot to dislike about Sirtex Medical. But its revolutionary liver cancer treatment works, the market for it is huge and the company is profitable and pays a dividend.
Why you should steer clear of NAB and ANZ
The big banks enjoyed a strong reporting season. But the strategies of National Australia Bank and ANZ make them our least preferred options in the sector.
Westpac boldly boosts dividend
This bank is struggling to grow its top line but falling bad debts are supporting impressive-looking profit growth in the short term. Investors should still tread carefully.
Soul Pattinson upgraded
Three different approaches to a sum-of-the-parts valuation reveals a mildly cheap investment company.
Cellestis passes the biotech test
In a world of biotech failures, Cellestis has developed a successful test for tuberculosis. The market’s response has been, ‘so what?’
Pay TV: All about the content
One of these companies is at the bottom of a big pipe and the other at the top. No prizes for guessing where Stokes and Packer sit. But should you follow them?
Wilson Investment Fund: Wind It Up
This listed investment company is worth more dead than alive. Rather than dither on strategy, the board should implement a mercy killing.
Worrying signs in ASX merger
The merger between ASX and its Singaporean counterpart is indeed a ‘great opportunity’. To eventually sell the stock, that is.
Breaking news: There's value in News Corp
Investors are currently getting a chance to buy News Corp on the cheap. And the fact that Murdoch won’t be around forever need not hold you back. It may even be a good thing.
Sell newspaper stocks: Read all about it
The newspaper sector was one of the worst places to have your money invested over the past decade. The next decade might well be worse. It's time to get out.
Spark Infrastructure upgraded
Five years late, the arguments made for infrastructure are about to bear fruit. A safe, growing 8.7% yield is now available, with the stock at a 42% discount to the $1.80 paid by float investors.
BHP and Rio: An unholy matrimony
The worst kept secret in mining is out; the merger of BHP and Rio’s iron ore operations is off. Gaurav Sodhi looks at what’s next for the two spurned giants
Tabcorp: The pain continues
The headlines have had the desired effect: distracting shareholders from lower dividends and yet another capital raising. Only the PR people can be happy.
Call 1300 880 160
Start a chat
Schedule a call
